EUVIMEDSkopri EUVIMED
Übersichtsarbeit

A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals

Mangesh Tiwaskar, Ketan K Mehta, Prabhu Kasture

Journal of the Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0480 ↗

At a glance

Übersichtsarbeit in Journal of the Association of Physicians of India, 2024. Written by Mangesh Tiwaskar and 2 co-authors. Institution: Consultant Physician and Diabetologist, Department of Diabetology, Shilpa Medical Research Centre, Mumbai, Maharashtra, India. Major MEDLINE topics: Hypertension, Antihypertensive Agents, Angiotensin II Type 1 Receptor Blockers, Blood Pressure. Cited 3 times so far (Crossref); 37 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

For >3 decades now, angiotensin receptor blockers (ARB) have been used in the management of hypertension (HTN) and HTN-related cardiovascular (CV) diseases. Olmesartan medoxomil (OLM) is an angiotensin II type 1 (AT1) receptor antagonist (or blocker) that binds tightly to the AT1 receptor with long-lasting efficacy over the 24-hour period and safety demonstrated in several trials. It is well tolerated and effective in reducing blood pressure (BP) in mono and combination therapy with thiazide diuretics or calcium channel blockers across a wide range of patient subgroups. The effectiveness and safety of OLM-based combination therapies have good and tolerable profiles with high adherence in the fixed single-pill formulation. Consistent antihypertensive efficacy and good tolerability when used as monotherapy or as a combined therapy make OLM a valuable treatment option for adults with HTN. In this review, we discuss the important clinical implications of OLM as an optimal choice as monotherapy and combination therapy in managing patients with HTN.

Subjects

MeSH terms (MEDLINE)

HypertensionAntihypertensive AgentsAngiotensin II Type 1 Receptor BlockersBlood PressureDrug Therapy, CombinationImidazolesHumansTetrazolesOlmesartan Medoxomil

Substances

Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersImidazolesTetrazolesOlmesartan Medoxomilolmesartan

Authors and institutions

  • Consultant Physician and Diabetologist, Department of Diabetology, Shilpa Medical Research Centre, Mumbai, Maharashtra, India.
  • Consulting Physician, Department of Medicine, Health Harmony, Mumbai, Maharashtra, India.
  • Deputy Director, Department of Medical Services and Pharmacovigilance, Blue Cross Laboratories Private Limited, Mumbai, Maharashtra, India, Corresponding Author.

Cite

APA

Tiwaskar, M., Mehta, K. K., & Kasture, P. (2024). A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals. Journal of the Association of Physicians of India. https://doi.org/10.59556/japi.72.0480

Vancouver

Tiwaskar M, Mehta KK, Kasture P. A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals. Journal of the Association of Physicians of India. 2024. doi:10.59556/japi.72.0480

BibTeX
@article{Tiwaskar2024,
  author = {Tiwaskar, Mangesh and Mehta, Ketan K and Kasture, Prabhu},
  title = {A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals},
  journal = {Journal of the Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0480}
}
Start for free →